About Abraham Bassan
Abraham Bassan is a director at Septerna.
Form D filings also name Abraham Bassan as a director at CARGO Therapeutics.
Abraham Bassan reports to the SEC as a director of 4 public companies, including Rani Therapeutics (RANI), CARGO Therapeutics (CRGX) and LENZ Therapeutics (LENZ).
Abraham Bassan first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Abraham Bassan in the role, so the role may have started earlier or lasted longer.
RI
Rani Therapeutics Holdings, Inc.
Director
2025 – 2026 · Public company (RANI)
LI
LENZ Therapeutics, Inc.
Director
2021 – 2023 · Public company (LENZ)
Key Colleagues at Startups
The people Abraham Bassan works with at each company, as listed on that company's latest Form D.
Septerna, Inc. · Form D, Jul 13, 2023
AE
Alan Ezekowitz
Director
RX
Ran Xiao
Executive officer
EB
Elizabeth Bhatt
Executive officer
JT
Jeffrey Tong
Director
JS
Jake Simson
Director
JF
Jeffrey Finer
Chief Executive Officer and director
SS
Samira Shaikhly
Executive officer
CARGO Therapeutics, Inc. · Form D, Mar 1, 2023
GC
Gina Chapman
Chief Executive Officer and director
CL
Cassandra Gianna Luca
Director
JW
Jeffrey Walsh
Director
KV
Krishnan Viswanadhan
Director
CM
Crystal Mackall
Director
HL
Heath Lukatch
Director
JO
John Orwin
Director
AR
Anup Radhakrishnan
Executive officer